This lease signals management's confidence in sustained test volume growth and oncology business expansion. The 2027 commencement suggests near-term capex is manageable; monitor upcoming 10-Q for updated test volume disclosure and any P&L impact of the ramp. The expansion of oncology-dedicated lab space by >3x is a positive signal for the segment's growth trajectory.
Price Chart
Executive Summary
BillionToOne signed a 12-year lease for ~62,659 sq ft of office/lab space at 3260 Whipple Road, Union City, CA, with aggregate base rent of ~$46.7M and a $12.5M tenant improvement allowance. The new lab will triple oncology-dedicated space and expand total facility space by ~16%, driven by test volumes exceeding plan over the last year.
Key Facts
- Lease for 62,659 sq ft office and lab space at 3260 Whipple Road, Union City, CA
- Initial term of 12 years with option to extend 10 more years at market rate
- Aggregate base rent over 12 years: approximately $46.7 million
- Landlord provides 12-month rent abatement and up to $12.5 million tenant improvement allowance
- Security deposit of $407,910 payable upon signing
- Lab space dedicated to oncology products, more than tripling current oncology-dedicated lab space
- Lease anticipated to commence on or about August 1, 2027 after tenant improvements
- Total facility space expands by approximately 16%
- Company states total test volumes have exceeded plan over the last year
Financial Impact
$46.7M aggregate base rent over 12 years + $12.5M tenant improvement allowance; security deposit $407,910
Risk Factors
- Lease obligation of ~$46.7M over 12 years adds fixed cost base; if growth stalls, occupancy costs become a drag
- Tenant improvements and build-out may require additional capital outlays beyond the $12.5M allowance
- Commencement in August 2027 leaves execution risk on construction timeline
- No revenue or earnings figures disclosed — cannot assess affordability relative to current cash flows
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0002070849-26-000042 |
| Document: 0002070849-26-000042-index-headers.html | 0002070849-26-000042 |
| Document: 0002070849-26-000042-index.html | 0002070849-26-000042 |
| Document: 0002070849-26-000042.txt | 0002070849-26-000042 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | Insider Cluster | $105.76 | awaiting T+60 | — | $114.16 (−7.94%) |
Sep 28, 2026 28d ago | Insider Cluster | $118.18 | awaiting T+60 | — | $114.16 (+3.40%) |
Sep 23, 2026 4w ago | Insider Cluster | $124.90 | awaiting T+60 | — | $114.16 (+8.60%) |
Sep 22, 2026 4w ago | Institutional Cluster | $116.07 | awaiting T+60 | — | $114.16 (−1.65%) |
Sep 21, 2026 5w ago | Insider Cluster | $116.07 | awaiting T+60 | — | $114.16 (+1.65%) |
Sep 16, 2026 5w ago | Insider Cluster | $110.67 | awaiting T+60 | — | $114.16 (−3.15%) |
Sep 11, 2026 6w ago | Insider Cluster | $100.82 | awaiting T+60 | — | $114.16 (+13.23%) |
Sep 11, 2026 6w ago | Insider Cluster | $100.82 | awaiting T+60 | — | $114.16 (+13.23%) |
Aug 27, 2026 8w ago | Insider Cluster | $93.24 | awaiting T+60 | — | $114.16 (+22.44%) |
Aug 27, 2026 8w ago | Insider Cluster | $93.24 | awaiting T+60 | — | $114.16 (+22.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers